Physician profile
Christian E Bartels
NPI 1508279100
$2,087.33
in general payments reported to CMS, 2019-2025
10 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.06 · 2020: $677 · 2021: $292 · 2022: $313 · 2023: $40.34 · 2024: $390 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $811.67 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $656.32 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $297.05 | 2021-2024 | Myrisk |
| Endo USA, INC. | $109.10 | 2025 | Xiaflex, Aveed |
| Neotract INC. | $85.49 | 2019-2020 | |
| Urogen Pharma, INC. | $40.34 | 2023 | Jelmyto |
| Immunitybio, INC. | $31.34 | 2024 | |
| Calyxo, INC. | $21.85 | 2024 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $20.19 | 2024 | Xiaflex, Aveed |
| Ambu INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Bartels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.